Abstract
Objective. Patients use and store considerable amounts of drugs. The aim of the present study was to identify potential drug-drug interactions between drugs used by patients recently discharged from the hospital and, subsequently, to estimate the clinical implications of these interactions. Methods. Patients were visited within 1 week following their discharge from hospital and interviewed about their drug use. Stored products were inspected. We used a bibliography (Hansten and Horn; Wolters Kluwer Health, St. Louis, Mo., 2004) to identify and classify potential drug-drug interactions. Results. In total, 83 surgical and 117 medical patients (n=200) were included in the survey, of which 139 (70%) were women. The median age was 75 years (range: 24–100 years). Patients stored 2119 medications at home (median: nine per patient; range: 2–44) and used 1622 medications daily or on demand (median: eight per patient; range: 1–24). With respect to those drugs used daily or on demand, 476 potential interactions were identified (126 patients); none were class 1 (always avoid drug combination) and 25 were class 2 (usually avoid combination; 24 patients). Eleven of the potential class 2 interactions involved over-the-counter products (aspirin and ginkgo biloba). Of the 52 drugs involved in potential class 2 interactions, 50 had been used for more than 1 month. According to the hospital case notes, none of the potential class 2 interactions had actually caused adverse effects. Conclusion. Although potential drug-drug interactions are highly prevalent, serious and clinically significant interactions are rare among recently hospitalised patients.
Similar content being viewed by others
References
Hallas J (1995) Drug related hospital admissions in subspecialities of internal medicine. PhD thesis/dissertation, Denmark
Einarson TR (1993) Drug-related hospital admissions. Ann Pharmacother 27:832–840
Hansten PD, Horn JD (2004) Drug interactions. Analysis and management. A clinical perspective and analysis of current developments. Facts and comparisons. Wolters Kluwer Health, St. Louis, Mo.
McInnes GT, Brodie MJ (1988) Drug interactions that matter. A critical reappraisal. Drugs 36:83–110
Doucet J, Chassagne P, Trivalle C, Landrin I, Pauty MD, Kadri N, Menard JF, Bercoff E (1996) Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 44:944–948
Egger SS, Drewe J, Schlienger RG (2003) Potential drug–drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol 58:773–778
Jankel CA, Speedie SM (1990) Detecting drug interactions: a review of the literature. DICP 24:982–989
Wittkowsky AK, Boccuzzi SJ, Wogen J, Wygant G, Patel P, Hauch O (2004) Frequency of concurrent use of warfarin with potentially interacting drugs. Pharmacotherapy 24:1668–1674
Guedon-Moreau L, Ducrocq D, Duc MF, Quieureux Y, L’Hote C, Deligne J, Caron J (2004) Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999. Eur J Clin Pharmacol 59:899–904
Durrence CW III, DiPiro JT, May JR, Nesbit RR Jr, Sisley JF, Cooper JW (1985) Potential drug interactions in surgical patients. Am J Hosp Pharm 42:1553–1556
Gronroos PE, Irjala KM, Huupponen RK, Scheinin H, Forsstrom J, Forsstrom JJ (1997) A medication database – a tool for detecting drug interactions in hospital. Eur J Clin Pharmacol 53:13–17
Kohler GI, Bode-Boger SM, Busse R, Hoopmann M, Welte T, Boger RH (2000) Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 38:504–513
Bjorkman IK, Fastbom J, Schmidt IK, Bernsten CB (2002) Drug-drug interactions in the elderly. Ann Pharmacother 36:1675–1681
Spagnoli A, Ostino G, Borga AD, D’Ambrosio R, Maggiorotti P, Todisco E, Prattichizzo W, Pia L, Comelli M (1989) Drug compliance and unreported drugs in the elderly. J Am Geriatr Soc 37:619–624
Barat I, Andreasen F, Damsgaard EM (2000) The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 56:501–509
Danish Medicines Agency, http://www.laegemiddelstyrelsen.dk
WHO Collaborating Centre for Drug Statistics Methodology (1998) Guidelines for ATC-classification and DDD assignment, 2nd edn. Oslo
Rosenblatt M, Mindel J (1997) Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 336:1108
Cadieux RJ (1989) Drug interactions in the elderly. How multiple drug use increases risk exponentially. Postgrad Med 86:179–186
Beers MH, Storrie M, Lee G (1990) Potential adverse drug interactions in the emergency room. An issue in the quality of care. Ann Intern Med 112:61–64
Glintborg B, Andersen SE, Spang-Hanssen E, Dalhoff K (2004) The use of over-the-counter drugs among surgical and medical patients. Eur J Clin Pharmacol 60:431–437
Glintborg B, Andersen SE, Spang-Hanssen E, Dalhoff K (2004) Disregarded use of herbal medical products and dietary supplements among surgical and medical patients as estimated by home inspection and interview. Pharmacoepidemiol Drug Saf (available online)
Lamy PP (1982) Over-the-counter medication: the drug interactions we overlook. J Am Geriatr Soc 30:S69–S75
Holden MD (1992) Over-the-counter medications. Do you know what your patients are taking? Postgrad Med 91:191–200
Peng CC, Glassman PA, Trilli LE, Hayes-Hunter J, Good CB (2004) Incidence and severity of potential drug-dietary supplement interactions in primary care patients: an exploratory study of 2 outpatient practices. Arch Intern Med 164:630–636
Corns CM (2003) Herbal remedies and clinical biochemistry. Ann Clin Biochem 40:489–507
Bjerrum L, Andersen M, Petersen G, Kragstrup J (2003) Exposure to potential drug interactions in primary health care. Scand J Prim Health Care 21:153–158
Wiltink EH (1998) Medication control in hospitals: a practical approach to the problem of drug-drug interactions. Pharm World Sci 20:173–177
Goldberg RM, Mabee J, Chan L, Wong S (1996) Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 14:447–450
Danish Medicines Agency, http://www.interaktionsdatabasen.dk
Jankel CA, Martin BC (1992) Evaluation of six computerized drug interaction screening programs. Am J Hosp Pharm 49:1430–1435
Linnarsson R (1993) Drug interactions in primary health care. A retrospective database study and its implications for the design of a computerized decision support system. Scand J Prim Health Care 11:181–186
Acknowledgements
The authors wish to thank Pharmacia/Pfizer for financial support and the nurses and secretaries at H:S Bispebjerg Hospital for their assistance. We thank E. Spang-Hanssen, MD, for assistance with the data collection.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Glintborg, B., Andersen, S.E. & Dalhoff, K. Drug-drug interactions among recently hospitalised patients – frequent but mostly clinically insignificant. Eur J Clin Pharmacol 61, 675–681 (2005). https://doi.org/10.1007/s00228-005-0978-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-005-0978-6